openPR Logo
Press release

Epidermolysis Bullosa Market Global Research and Clinical Analysis 2021 to 2030

07-29-2021 12:42 PM CET | Health & Medicine

Press release from: Market Insights Reports

The Epidermolysis Bullosa Market report provides a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Epidermolysis Bullosa study provides comprehensive data which enhances the understanding, scope and application of this report. This report also provides an analysis of the impact of the COVID-19 pandemic on Epidermolysis Bullosa Industry.

Get Free Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/10232393810/epidermolysis-bullosa-market-insight-epidemiology-and-market-forecast-2030/inquiry?Mode=11                                                       

Market Overview:

Epidermolysis Bullosa (EB) is a group of skin diseases that cause various degrees of skin and mucous membrane fragility. The skin becomes fragile when proteins essential for skin integrity are absent, reduced, or abnormal. It is characterized by blister formation in response to mechanical trauma. EB is generally caused by mutations involving at least 18 genes encoding structural proteins within keratin intermediate filaments, focal adhesions, desmosome cell junctions, and hemidesmosome attachment complexes, which form the intraepidermal adhesion and dermo-epidermal anchoring complex within the basement membrane zone (BMZ) of the skin and mucosae.

Key Findings:
- The total diagnosed prevalent cases of EB in the 7MM was 39,433 in 2017.
- In 2017, there were 26,104 prevalent cases of EB in the United States. In the same years, there were a total of 24,799 diagnosed prevalent cases of EB in the United States.
- In 2017, there were 14,879 cases of EBS, 1,240 cases of JEB, and 8,680 cases of DEB in the United States. DEB is further divided as recessive and dominant.
- Out of 8,680 cases of DEB in the United States in 2017, 4,554 cases were dominant DEB and 4,126 cases were recessive DEB.
- Among the European countries, the United Kingdom had the highest prevalent population of EB with 5,037 cases, followed by Germany which had a prevalent population of 4,919 in 2017. On the other hand, Spain had the lowest prevalent population of 928 in 2017.

The regions are further sub-divided into:

-North America (NA) – US, Canada, and Mexico
-Europe (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of Europe
-Asia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APAC
-Latin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin America
-Middle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South Africa

Browse Full Report at:

https://www.marketinsightsreports.com/reports/10232393810/epidermolysis-bullosa-market-insight-epidemiology-and-market-forecast-2030?Mode=11                                                                

Following are major Table of Content of Epidermolysis Bullosa Market:

-An overall analysis of industry trends.
-Global Epidermolysis Bullosa market overview.
-Major commercial developments in the Epidermolysis Bullosa industry.
-Detailed information about drivers, opportunities, and restraints of the Epidermolysis Bullosa market
-Positioning of major market participants in the Epidermolysis Bullosa industry.
-Competitive Landscape and analysis regarding Epidermolysis Bullosa market and key product segments of a market.
-Epidermolysis Bullosa market revenue and forecast analysis, by type, application, end-user and geography.
-Key market trends and future growth prospects of the Epidermolysis Bullosa market.

We Offer Customization On Report Based On Specific Client Requirement:

–Free Country Level analysis for any 5 countries of your choice.
–Free Competitive analysis of any 5 key market players.
–Free 40 analyst hours to cover any other data point.

Contact US:
Irfan Tamboli (Head of Sales): Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epidermolysis Bullosa Market Global Research and Clinical Analysis 2021 to 2030 here

News-ID: 2340871 • Views:

More Releases from Market Insights Reports

Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, Honeywell
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world. Some of the key players
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, Grupo Antolin
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Smucker
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Precision Planting Market is Set to Fly High in Years to Come
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in

All 5 Releases


More Releases for Epidermolysis

Epidermolysis Bullosa Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Epidermolysis Bullosa Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Epidermolysis Bullosa Research. Learn more about
Epidermolysis Bullosa Pipeline, Clinical Trials Assessment, and FDA Approvals 20 …
DelveInsight's, "Epidermolysis Bullosa Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Epidermolysis Bullosa pipeline landscape. It covers the Epidermolysis Bullosa pipeline drug profiles, including Epidermolysis Bullosa clinical trials and nonclinical stage products. It also covers the Epidermolysis Bullosa therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways
Epidermolysis Bullosa Market to Reach US$ 3,856.2 Million by 2033
Market Overview: The 7 major epidermolysis bullosa markets reached a value of US$ 2,496.5 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 3,856.2 Million by 2033, exhibiting a growth rate (CAGR) of 4% during 2023-2033. The report offers a comprehensive analysis of the epidermolysis bullosa market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as
Singapore Dystrophic Epidermolysis Bullosa Treatment Market to Observe Strong De …
Dystrophic Epidermolysis Bullosa Treatment Market: Introduction According to the report, the global dystrophic epidermolysis bullosa treatment market was valued over US$ 412 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. Dystrophic epidermolysis bullosa (DEB) is the second most common form of epidermolysis bullosa. The prevalence of DEB varies from 1 per 49,000 inhabitants in Scotland to 1 per 420,168 in the U.S. According to the U.S. National Library of Medicine,
Epidermolysis Bullosa Market Insights, Share, Size, Companies, and Forecast 2032
DelveInsight's Epidermolysis Bullosa Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Epidermolysis Bullosa Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). The Epidermolysis Bullosa Market report covers emerging drugs, current treatment practices, market share of individual therapies, and the current forecasted market size
Epidermolysis Bullosa Therapeutics Market Promising Growth Opportunities and For …
Global Epidermolysis Bullosa Therapeutics Market: Overview Epidermolysis Bullosa (EB) is a rare genetic diseases skin tissue. The skin of people suffering from EB becomes fragile. This can lead to the blisters and wounds are very difficult to heal. Symptoms related to this disorder such as blistering of skin, toenails, deformity or loss of fingernails, and internal blistering such as throat, stomach, esophagus, intestines and urinary tract. Also, it witnesses the skin